Calcitonin Gene-related Peptide Receptor Antagonist
8 drugs across 3 manufacturers|0 Generic,8 Brand
Total Drugs
8
0G / 8B
Manufacturers
3
Avg $95.2015/unit
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
8 flat
of 8 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
3 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ZAVZPRET 10 MG NASAL SPRAY zavegepant | $190.1660 per EA | — |
NURTEC ODT 75 MG TABLET rimegepant sulfate | $128.7461 per EA | — |
UBRELVY 100 MG TABLET ubrogepant | $109.1882 per EA | — |
UBRELVY 100 MG TABLET ubrogepant | $109.1882 per EA | — |
UBRELVY 50 MG TABLET ubrogepant | $109.0773 per EA | — |
QULIPTA 60 MG TABLET Atogepant | $38.4749 per EA | — |
QULIPTA 30 MG TABLET Atogepant | $38.4048 per EA | — |
QULIPTA 10 MG TABLET Atogepant | $38.3668 per EA | — |